News Author: Daniel M. Keller Publish date: June 13, 2016
Key clinical point: Adding ipilimumab to nivolumab resulted in better responses in SCLC than nivolumab alone.
Major finding: Among 216 patients, r...
News Author: Daniel M. Keller Publish date: June 13, 2016
News Author: Daniel M. Keller Publish date: June 12, 2016
Despite improvements, survivors of childhood cancers still face long-term risks in terms of secondary neoplasms, nonsurgical premature menopause (NSPM...
News Author: Daniel M. Keller Publish date: June 10, 2016
Key clinical point: A Web-based app improves survival for advanced lung cancer patients.
Major finding: Survival improved by 26% for web-app patie...
News Author: Daniel M. Keller Publish date: June 10, 2016
Key clinical point: End-of-life aggressive cancer care continues unabated despite Choosing Wisely recommendations.
Major finding: Three-quarters o...
News Author: Daniel M. Keller Publish date: June 10, 2016
Key clinical point: Combining temozolomide with radiotherapy prolongs survival for elderly with glioblastoma.
Major finding: Combining temozolomid...
News Author: Daniel M. Keller Publish date: June 9, 2016
Key clinical point: Neuroblastoma event-free survival was better with tandem than with single ASCT.
Major finding: Event-free survival was 61% wit...
News Author: Daniel M. Keller Publish date: June 9, 2016
ORLANDO – There is now an awareness of a spectrum of gender identity and an affirmation of the right of individuals to express that identity as they w...
News Author: Daniel M. Keller Publish date: June 8, 2016
Key clinical point: IL-2 adds no benefit, only toxicity, to neuroblastoma antibody therapy.
Major finding: Only 61% of treatment cycles were comp...
News Author: Daniel M. Keller Publish date: June 7, 2016
News Author: Daniel M. Keller Publish date: June 7, 2016
News Author: Daniel M. Keller Publish date: June 7, 2016
Key clinical point: Feedback from a system of digital-enabled pills enhanced medication adherence.
Major finding: Patients using Proteus had 84% a...
News Author: Daniel M. Keller Publish date: June 7, 2016
Key clinical point: A novel monoclonal antibody in combination with chemotherapy increased overall and progression-free survival in advanced gastr...
News Author: Daniel M. Keller Publish date: June 6, 2016
Black, Hispanic, and white women differ in BRCA risk management.
News Author: Daniel M. Keller Publish date: June 4, 2016
Key clinical point: Adjuvant temozolomide post-radiation improves survival in non-1p/19q-deleted anaplastic glioma.
Major finding: Adjuvant temoz...
